Stay updated with breaking news from Mcdaniel Terry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Koss Olinger Consulting LLC reduced its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 16.4% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,592 shares of the biopharmaceutical company’s stock after selling 704 shares during the quarter. Koss Olinger Consulting LLC’s holdings in […]
Independent Advisor Alliance lowered its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.7% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,610 shares of the biopharmaceutical company’s stock after selling 284 shares during the period. Independent Advisor […]
Cantor Fitzgerald restated their overweight rating on shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. They currently have a $75.00 target price on the biopharmaceutical company’s stock. A number of other equities research analysts have also recently issued reports on BMY. TD Cowen […]
Invst LLC grew its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 6.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,839 shares of the biopharmaceutical company’s stock after purchasing an additional 289 shares during the period. Invst LLC’s holdings in Bristol-Myers Squibb were […]
Inlet Private Wealth LLC lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 64,502 shares of the biopharmaceutical company’s stock after acquiring an additional 875 shares during the quarter. Bristol-Myers Squibb […]